Global Biopsy Guns and Needles Market, By Product Type (Disposable, Reusable), Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, Others), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, Others), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Biopsy Guns and Needles Market
Biopsy guns and needles market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 144.61 million by 2028 and will grow at a CAGR of 3.88% in the above mentioned forecast period.
Biopsy needles are the type of medical instrument used to perform a biopsy, which is a process to obtain a sample of cells from your body for laboratory testing. Biopsy gun is a fully- automatic cutting ease device, which is easy to install, special fixation handle and helps to provide a high success rate in punctures.
The rapid innovation and technological advancements is amongst the important factor expected to intensify the growth and demand of biopsy guns and needles market. In addition, the increase in the growth in incidence of cancer across the globe and liver across the globe and rise in the number of patients undergoing biopsies are also expected contributes to the growth in the global market over the forecast period of 2021 to 2028. Also the rise in the government initiatives and rapid rise in the instances of chronic medical ailments, particularly breast cancer are also likely to enhance the growth of the market. Furthermore, the rise in the consumer awareness regarding the availability of diagnostic and screening procedures for chronic diseases are also amongst the significant factors expected
The rise in the preference for minimally invasive surgeries, increase in the healthcare expenditure and rise in the research and development (R&D) activities are anticipated to offer significant growth opportunities for the biopsy guns and needles market in the forecast period of 2021 to 2028.
However, the product recalls and the high risk of infections are expected to curb the growth of the biopsy guns and needles market, whereas the underdeveloped healthcare infrastructure and dearth of resources in developing countries can challenge the growth of the biopsy guns and needles market.
This biopsy guns and needles market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on biopsy guns and needles market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Biopsy Guns and Needles Market Scope and Market Size
Biopsy guns and needles market is segmented on the basis of product type, technique, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the biopsy guns and needles market is segmented into disposable and reusable.
- Based on technique, the biopsy guns and needles market is segmented into ultrasound-guided biopsy, stereotactic-guided biopsy, MRI-guided biopsy and others.
- Based on application, the biopsy guns and needles market is segmented into breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy and others.
- On the basis of end user, the biopsy guns and needles market is segmented into hospitals, academic and research institutes, diagnostic and imaging centers and others.
Biopsy Guns and Needles Market Country Level Analysis
Biopsy guns and needles market is analyzed and market size insights and trends are provided by country, product type, technique, application and end user as referenced above.
The countries covered in the biopsy guns and needles market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the biopsy guns and needles market owing to the rise in the R&D expenditure and the rise in the incidence of cancer, particularly in developed nations. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rise in awareness regarding biopsy procedures and increase in ageing population.
The country section of the biopsy guns and needles market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Biopsy guns and needles market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for biopsy guns and needles market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the biopsy guns and needles market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Biopsy Guns and Needles Market Share Analysis
Biopsy guns and needles market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to biopsy guns and needles market.
The major players covered in the biopsy guns and needles market report are Cardinal Health, BD, Medax SRL, Creganna, Möller Medical GmbH, ARGON MEDICAL, DTR Medical Ltd., Hologic, Inc., INRAD, Inc., Cook, B. Braun Melsungen AG, Olympus Corporation, Boston Scientific Corporation, Merit Medical Systems, Ranfac Corp., FUJIFILM Corporation, Medtronic, CONMED Corporation, Stryker and SOMATEX Medical Technologies GmbH among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-